Clinical Trial Update: Study With Phage for CF Subjects With Pseudomonas Lung Infection [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by BiomX Ltd is evaluating phage therapy for chronic Pseudomonas aeruginosa lung infection in people with cystic fibrosis; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pseudomonas Aeruginosa Infection

Drugs mentioned

• Bacteriophage therapy

Snippet

Sponsor: BiomX Ltd | Conditions: Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis (CF) | Phase 2 | Status: RECRUITING